NSW Health WSLHD Safety & Quality Account 2020-21

Using Research, Technology and Data to Drive Quality Improvement

Westmead Health Precinct

WSLHD views research, technology, and data to drive quality improvement in healthcare as essential for delivering effective patient care. Over the past 12 months, WSLHD has incorporated cutting-edge technology and data analytics to enable real-time monitoring of patient progress, identification of trends, and informed decision-making, ultimately fostering a culture of continuous improvement and raising the overall standard of care in our organisation. Over 2,200 Research Studies Over 700 Pharmaceutical sponsored trials Over $70 Million Of income received through research studies OUR STATS AT A GLANCE

“There are over 2000 research projects underway every year at the Westmead Health Precinct, which is quite a significant piece of work,” –Graeme Loy, WSLHD Chief Executive. In early 2023, WSLHD hosted international delegates as part of the MedInfo Conference to learn from industry leading digital health professionals. The Precinct has continued to grow over the last 12 months with developments in: 1. Advanced therapeutics 2. Translational cancer 3. Digital health and ‘Big Data’ 4. Infectious disease, immunology, and vaccinology 5. Clinical trials

International Delegates hosted in Westmead Precinct during MedInfo Conference

Safety & Quality Account 2022-2023 Western Sydney Local Health District

38